In the beginning of December, the European Network of Health Technology Assessment (EUnetHTA) performed evaluation of reimbursement and HTA process in 31 EUnetHTA partner countries. The aim of the study was to improve HTA cooperation between countries, use jointly produced HTA information and re-use national, regional HTA information.
For this purpose HTA agencies and decision-makers who use HTA information were asked by EUnetHTA to provide description of HTA and reimbursement of pharmaceutical and non-pharmaceutical health technologies in outpatient and inpatients settings.
In results, data for analysis were received from 59 agencies. Information was extracted into Excel tables and gathered in following topics:
- Description of HTA process
- Horizon scanning and topic selection
- Description of HTA assessment process
- Advice and decision making
- Legal and procedural issues
- Stakeholder involvement
Additionally, EUnetHTA analyzed restrictions regarding type of technology for assessment, timelines for procedures, number of topics for assessment, types (single technology assessment, multiple technology assessment) and approaches (relative effectiveness assessment, clinical effectiveness, economical analyses and full HTA) of initial assessment of health technologies in majority of European countries.
See full report in English here
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.